Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kolbe, H.
Right arrow Articles by Marsden, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolbe, H.
Right arrow Articles by Marsden, C. D.
NEUROLOGY 1981;31:434
© 1981 American Academy of Neurology

Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors

H. Kolbe, A. Clow, P. Jenner and C. D. Marsden

University Department of Neurology, Institute of Psychiatry, and King's College Hospital Medical School, Denmark Hill, London, England.

oral administration of butaperazine (40 mg per kilogram) to rats increased dopamine turnover, as measured by elevation of striatal and mesolimbic concentrations of homovanillic acid and 3,4-dihydroxyphen-ylacetic acid, for 24 to 48 hours. Initially, this dose of butaperazine inhibited stereotyped behavior in response to subcutaneous administration of apomorphine, but this effect was reversed at 12 hours. Later, animals had normal or exaggerated responses to apomorphine. The data suggest that at the critical 20- to 28-hour period after butaperazine administration, when most human acute dystonic reactions occur, normal or supersensitive cerebral dopamine receptors are exposed to an excessive synaptic release of dopamine. This may be responsible for the drug-induced dystonia.

Address correspondence and reprint requests to Dr. Marsden, University Department of Neurology, Institute of Psychiatry and King's College Hospital Medical School, Denmark Hill, London SE5, UK.

Accepted for publication July 22, 1980.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. S. Perlmutter, M. K. Stambuk, J. Markham, K. J. Black, L. McGee-Minnich, J. Jankovic, and S. M. Moerlein
Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia
J. Neurosci., January 15, 1997; 17(2): 843 - 850.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.